On October 4, 2017, Monsanto (MON) reported its fiscal 4Q17 and fiscal 2017 earnings. It delivered EPS (earnings per share) of $0.05, which was better than a loss of $0.44 in the corresponding quarter a year ago. For fiscal 2017, the company reported EPS of $5.09, which rose from $2.99 in fiscal 2016.
With the anticipation of completing a merger with Bayer next year, Monsanto’s management said this may be its final full-year earnings call as Monsanto.
How the market reacted
Monsanto’s ongoing EPS rose year-over-year from $0.07 to $0.20 in fiscal 4Q17, and for fiscal 2017, it rose year-over-year from $4.48 to $5.50. Its ongoing EPS was adjusted to exclude items that Monsanto doesn’t believe are part of its ongoing business.
After it released its fiscal 4Q17 earnings, MON stock ended almost flat at $119.75, which was down 6 basis points from the previous day’s close.
During the day, Syngenta (SYT) also ended almost flat. However, FMC (FMC) rose 71 basis points, and DowDuPont (DWDP) rose 16 basis points during the day. Over the same period, the S&P 500 Index (SPY) rose slightly by 5 basis points.
In this earnings overview series, we’ll look at some of the key metrics for Monsanto’s 4Q17 earnings results. We’ll also see what management’s outlook is for the company and provide an update on the timeline for Monsanto’s merger with Bayer.
First, let’s look at Monsanto’s sales by segments.